The metabolic landscape of lung cancer: New insights in a disturbed glucose metabolism

Hallmarks of Cancer: The Next Generation

Hanahan, D., & Weinberg, R. A. (2011) · Cell · doi:10.1016/j.cell.2011.02.013 · Cited by 66,590 · see citing works

Cancer incidence and mortality worldwide: Sources, methods and major patterns in GLOBOCAN 2012

Ferlay, J., Soerjomataram, I., Dikshit, R., Eser, S., Mathers, C., Rebelo, M., Parkin, D. M., Forman, D., & Bray, F. (2015) · International Journal of Cancer · doi:10.1002/ijc.29210 · Cited by 28,766 · see citing works

Global cancer statistics, 2012

Torre, L. A., Bray, F., Siegel, R. L., Ferlay, J., Lortet‐Tieulent, J., & Jemal, A. (2015) · CA A Cancer Journal for Clinicians · doi:10.3322/caac.21262 · Cited by 26,858 · see citing works

On the origin of cancer cells

Warburg, O. (1956) · Science · doi:10.1126/science.123.3191.309 · Cited by 13,425 · see citing works

Pembrolizumab versus Chemotherapy for PD-L1-Positive Non-Small-Cell Lung Cancer

Reck, M., Rodríguez-Abreu, D., Robinson, A. G., Hui, R., Csőszi, T., Fülöp, A., Gottfried, M., Peled, N., Tafreshi, A., Cuffe, S., et al. (2016) · New England Journal of Medicine · doi:10.1056/nejmoa1606774 · Cited by 10,089 · see citing works

The Warburg Effect: How Does it Benefit Cancer Cells?

Liberti, M. V., & Locasale, J. W. (2016) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2015.12.001 · Cited by 5,150 · see citing works

Regulation of cancer cell metabolism

Cairns, R. A., Harris, I. S., & Mak, T. W. (2011) · Nature Reviews Cancer · doi:10.1038/nrc2981 · Cited by 4,744 · see citing works

HIF-1-mediated expression of pyruvate dehydrogenase kinase: A metabolic switch required for cellular adaptation to hypoxia

Kim, J.-W., Tchernyshyov, I., Semenza, G. L., & Dang, C. V. (2006) · Cell Metabolism · doi:10.1016/j.cmet.2006.02.002 · Cited by 3,905 · see citing works

Reactive oxygen species in cancer

Liou, G., & Störz, P. (2010) · Free Radical Research · doi:10.3109/10715761003667554 · Cited by 3,394 · see citing works

A guide to immunometabolism for immunologists

O'Neill, L. A. J., Kishton, R. J., & Rathmell, J. (2016) · Nature Reviews Immunology · doi:10.1038/nri.2016.70 · Cited by 3,315 · see citing works

Fundamentals of Cancer Metabolism

DeBerardinis, R. J., & Chandel, N. S. (2016) · Science Advances · doi:10.1126/sciadv.1600200 · Cited by 3,013 · see citing works

Insulin and insulin-like growth factor signalling in neoplasia

Pollak, M. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2536 · Cited by 2,059 · see citing works

Transcriptional regulation of genes encoding glycolytic enzymes by hypoxia-inducible factor 1.

Semenza, G., Roth, P. H., Fang, H. M., & Wang, G. L. (1994) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(17)31580-6 · Cited by 1,892 · see citing works

Defining the role of hypoxia-inducible factor 1 in cancer biology and therapeutics

Semenza, G. L. (2010) · Oncogene · doi:10.1038/onc.2009.441 · Cited by 1,712 · see citing works

Macropinocytosis of protein is an amino acid supply route in Ras-transformed cells

Commisso, C., Davidson, S. M., Soydaner-Azeloglu, R. G., Parker, S. J., Kamphorst, J. J., Hackett, S., Grabocka, E., Nofal, M., Drebin, J. A., Thompson, C. B., et al. (2013) · Nature · doi:10.1038/nature12138 · Cited by 1,683 · see citing works

Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice

Sonveaux, P., Végran, F., Schroeder, T., Wergin, M., Verrax, J., Rabbani, Z. N., Saedeleer, C. J. D., Kennedy, K. M., Diepart, C., Jordan, B. F., et al. (2008) · Journal of Clinical Investigation · doi:10.1172/jci36843 · Cited by 1,635 · see citing works

Attenuation of LDH-A expression uncovers a link between glycolysis, mitochondrial physiology, and tumor maintenance

Fantin, V. R., St-Pierre, J., & Leder, P. (2006) · Cancer Cell · doi:10.1016/j.ccr.2006.04.023 · Cited by 1,635 · see citing works

Reflecting on 25 years with MYC

Meyer, N., & Penn, L. Z. (2008) · Nature Reviews Cancer · doi:10.1038/nrc2231 · Cited by 1,575 · see citing works

A Mitochondria-K+ Channel Axis Is Suppressed in Cancer and Its Normalization Promotes Apoptosis and Inhibits Cancer Growth

Bonnet, S., Archer, S. L., Allalunis‐Turner, J., Haromy, A., Beaulieu, C., Thompson, R. B., Lee, C. T., Lopaschuk, G. D., Puttagunta, L., Bonnet, S. B., et al. (2007) · Cancer Cell · doi:10.1016/j.ccr.2006.10.020 · Cited by 1,530 · see citing works

Inhibition of lactate dehydrogenase A induces oxidative stress and inhibits tumor progression

Le, A., Cooper, C. R., Gouw, A. M., Dinavahi, R., Maitra, A., Deck, L. M., Royer, R. E., Jagt, D. L. V., Semenza, G. L., & Dang, C. V. (2010) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0914433107 · Cited by 1,528 · see citing works

KRAS Mutations and Primary Resistance of Lung Adenocarcinomas to Gefitinib or Erlotinib

Pao, W. J., Wang, T. Y., Riely, G. J., Miller, V. A., Pan, Q., Ladanyi, M., Zakowski, M. F., Heelan, R. T., Kris, M. G., & VARMUS, H. E. (2005) · PLoS Medicine · doi:10.1371/journal.pmed.0020017 · Cited by 1,517 · see citing works

Akt Stimulates Aerobic Glycolysis in Cancer Cells

Elstrom, R. L., Bauer, D. E., Buzzai, M., Karnauskas, R., Harris, M. H., Plas, D. R., Zhuang, H., Cinalli, R. M., Alavi, A., Rudin, C. M., et al. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-2904 · Cited by 1,454 · see citing works

Mutations in the Epidermal Growth Factor Receptor and in KRAS Are Predictive and Prognostic Indicators in Patients With Non–Small-Cell Lung Cancer Treated With Chemotherapy Alone and in Combination With Erlotinib

Eberhard, D. A., Johnson, B. E., Amler, L. C., Goddard, A. D., Heldens, S., Herbst, R. S., Ince, W. L., Janne, P. A., Januario, T., Johnson, D. H., et al. (2005) · Journal of Clinical Oncology · doi:10.1200/jco.2005.02.857 · Cited by 1,453 · see citing works

The pentose phosphate pathway and cancer

Patra, K. C., & Hay, N. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.06.005 · Cited by 1,444 · see citing works

The reverse Warburg effect: Aerobic glycolysis in cancer associated fibroblasts and the tumor stroma

Pavlides, S., Whitaker-Menezes, D., Castello-Cros, R., Flomenberg, N., Witkiewicz, A. K., Frank, P. G., Casimiro, M. C., Wang, C., Fortina, P., Addya, S., et al. (2009) · Cell Cycle · doi:10.4161/cc.8.23.10238 · Cited by 1,391 · see citing works

MYC, Metabolism, and Cancer

Stine, Z. E., Walton, Z. E., Altman, B. J., Hsieh, A. L., & Dang, C. V. (2015) · Cancer Discovery · doi:10.1158/2159-8290.cd-15-0507 · Cited by 1,375 · see citing works

Lactate Metabolism in Human Lung Tumors

Faubert, B., Li, K. Y., Cai, L., Hensley, C. T., Kim, J., Zacharias, L. G., Yang, C., Do, Q. N., Doucette, S., Burguete, D., et al. (2017) · Cell · doi:10.1016/j.cell.2017.09.019 · Cited by 1,343 · see citing works

Inhibition of Pyruvate Kinase M2 by Reactive Oxygen Species Contributes to Cellular Antioxidant Responses

Anastasiou, D., Poulogiannis, G., Asara, J. M., Boxer, M. B., Jiang, J., Shen, M., Bellinger, G., Sasaki, A. T., Locasale, J. W., Auld, D. S., et al. (2011) · Science · doi:10.1126/science.1211485 · Cited by 1,196 · see citing works

Oxidative Phosphorylation as an Emerging Target in Cancer Therapy

Ashton, T. M., McKenna, W. G., Kunz‐Schughart, L. A., & Higgins, G. S. (2018) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-17-3070 · Cited by 1,144 · see citing works

Metabolic heterogeneity in human lung tumors

Hensley, C. T., Faubert, B., Yuan, Q., Lev-Cohain, N., Jin, E., Kim, J., Jiang, L., Ko, B., Skelton, R., Loudat, L., et al. (2016) · Cell · doi:10.1016/j.cell.2015.12.034 · Cited by 1,138 · see citing works

Proliferation, survival and metabolism: the role of PI3K/AKT/mTOR signalling in pluripotency and cell fate determination

Yu, J., & Cui, W. (2016) · Development · doi:10.1242/dev.137075 · Cited by 1,137 · see citing works

Transcriptional regulation and transformation by Myc proteins

Adhikary, S., & Eilers, M. (2005) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm1703 · Cited by 1,122 · see citing works

Energy metabolism in tumor cells

Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Marín‐Hernández, Á., & Saavedra, E. (2007) · FEBS Journal · doi:10.1111/j.1742-4658.2007.05686.x · Cited by 1,086 · see citing works

P53 in survival, death and metabolic health: a lifeguard with a licence to kill.

Kruiswijk, F., Labuschagne, C. F., & Vousden, K. H. (2015) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm4007 · Cited by 1,080 · see citing works

Serine and glycine metabolism in cancer

Amelio, I., Cutruzzolà, F., Antonov, A., Agostini, M., & Melino, G. (2014) · Trends in Biochemical Sciences · doi:10.1016/j.tibs.2014.02.004 · Cited by 1,056 · see citing works

Targeting the PI3K pathway in cancer: are we making headway?

Janku, F., Yap, T. A., & Meric-Bernstam, F. (2018) · Nature Reviews Clinical Oncology · doi:10.1038/nrclinonc.2018.28 · Cited by 1,033 · see citing works

Serine and one-carbon metabolism in cancer

Yang, M., & Vousden, K. H. (2016) · Nature Reviews Cancer · doi:10.1038/nrc.2016.81 · Cited by 992 · see citing works

Hypoxia-Inducible Factors: Master Regulators of Cancer Progression

Schito, L., & Semenza, G. L. (2016) · Trends in Cancer · doi:10.1016/j.trecan.2016.10.016 · Cited by 962 · see citing works

How cancer metabolism is tuned for proliferation and vulnerable to disruption

Schulze, A., & Harris, A. L. (2012) · Nature · doi:10.1038/nature11706 · Cited by 927 · see citing works

Influence of Metabolism on Epigenetics and Disease

Kaelin, W. G., & McKnight, S. L. (2013) · Cell · doi:10.1016/j.cell.2013.03.004 · Cited by 920 · see citing works

c-Myc and Cancer Metabolism

Miller, D. M., Thomas, S. D., Islam, A., Muench, D. E., & Sedoris, K. C. (2012) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-12-0977 · Cited by 844 · see citing works

p53 regulates biosynthesis through direct inactivation of glucose-6-phosphate dehydrogenase

Jiang, P., Du, W., Wang, X., Mancuso, A., Gao, X., Wu, M., & Yang, X. (2011) · Nature Cell Biology · doi:10.1038/ncb2172 · Cited by 798 · see citing works

Environment impacts the metabolic dependencies of Ras-driven non-small cell lung cancer

Davidson, S. M., Papagiannakopoulos, T., Olenchock, B. A., Heyman, J. E., Keibler, M. A., Luengo, A., Bauer, M. R., Jha, A. K., O’Brien, J. P., Pierce, K. A., et al. (2016) · Cell Metabolism · doi:10.1016/j.cmet.2016.01.007 · Cited by 737 · see citing works

Pyruvate kinase type M2: A key regulator of the metabolic budget system in tumor cells

Mazurek, S. (2011) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.02.005 · Cited by 694 · see citing works

Phosphofructokinase 1 Glycosylation Regulates Cell Growth and Metabolism

Yi, W., Clark, P. M., Mason, D. E., Keenan, M. C., Hill, C., Goddard, W. A., Peters, E. C., Driggers, E. M., & Hsieh‐Wilson, L. C. (2012) · Science · doi:10.1126/science.1222278 · Cited by 680 · see citing works

Genes of glycolysis are ubiquitously overexpressed in 24 cancer classes

Altenberg, B., & Greulich, K. O. (2004) · Genomics · doi:10.1016/j.ygeno.2004.08.010 · Cited by 662 · see citing works

Glycine decarboxylase activity drives non-small cell lung cancer tumor-initiating cells and tumorigenesis

Zhang, W. C., Shyh-Chang, N., Yang, H., Rai, A., Umashankar, S., Ma, S., Soh, B. S., Sun, L. L., Tai, B. C., Nga, M. E., et al. (2012) · Cell · doi:10.1016/j.cell.2011.11.050 · Cited by 660 · see citing works

A key role for mitochondrial gatekeeper pyruvate dehydrogenase in oncogene-induced senescence

Kaplon, J., Zheng, L., Meissl, K., Chaneton, B., Selivanov, V. A., Mackay, G., van der Burg, S. H., Verdegaal, E. M. E., Cascante, M., Shlomi, T., et al. (2013) · Nature · doi:10.1038/nature12154 · Cited by 633 · see citing works

Cancer metabolism: facts, fantasy, and fiction

Zu, X. L., & Guppy, M. (2003) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2003.11.136 · Cited by 618 · see citing works

Pyruvate kinase: Function, regulation and role in cancer

Israelsen, W. J., & Heiden, M. G. V. (2015) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2015.08.004 · Cited by 593 · see citing works

LKB1 Inactivation Dictates Therapeutic Response of Non-Small Cell Lung Cancer to the Metabolism Drug Phenformin

Shackelford, D. B., Abt, E., Gerken, L., Vasquez, D. S., Seki, A., Leblanc, M., Wei, L., Fishbein, M. C., Czernin, J., Mischel, P. S., et al. (2013) · Cancer Cell · doi:10.1016/j.ccr.2012.12.008 · Cited by 585 · see citing works

Cancer metabolism and the Warburg effect: the role of HIF-1 and PI3K

Courtnay, R., Ngo, D. C., Malik, N., Ververis, K., Tortorella, S. M., & Karagiannis, T. C. (2015) · Molecular Biology Reports · doi:10.1007/s11033-015-3858-x · Cited by 570 · see citing works

Targeting GLUT1 and the Warburg Effect in Renal Cell Carcinoma by Chemical Synthetic Lethality

Chan, D. A., Sutphin, P. D., Nguyen, P., Turcotte, S., Lai, E. W., Banh, A., Reynolds, G. E., Chi, J., Wu, J. J., Solow-Cordero, D. E., et al. (2011) · Science Translational Medicine · doi:10.1126/scitranslmed.3002394 · Cited by 563 · see citing works

A Small-Molecule Inhibitor of Glucose Transporter 1 Downregulates Glycolysis, Induces Cell-Cycle Arrest, and Inhibits Cancer Cell Growth In Vitro and In Vivo

Liu, Y., Cao, Y., Zhang, W., Bergmeier, S. C., Qian, Y., Akbar, H., Colvin, R. A., Ding, J., Tong, L., Wu, S., et al. (2012) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-12-0131 · Cited by 563 · see citing works

A census of amplified and overexpressed human cancer genes

Santarius, T., SHIPLEY, J. M., Brewer, D. S., Stratton, M. R., & Cooper, C. S. (2009) · Nature reviews. Cancer · doi:10.1038/nrc2771 · Cited by 550 · see citing works

GAPDH and Autophagy Preserve Survival after Apoptotic Cytochrome c Release in the Absence of Caspase Activation

Colell, A., Ricci, J.-E., Tait, S., Milasta, S., Maurer, U., Bouchier-Hayes, L., Fitzgerald, P., Guio-Carrion, A., Waterhouse, N. J., Li, C. W., et al. (2007) · Cell · doi:10.1016/j.cell.2007.03.045 · Cited by 516 · see citing works

Shikonin and its analogs inhibit cancer cell glycolysis by targeting tumor pyruvate kinase-M2

Chen, J., Xie, J., Jiang, Z., Wang, B., Wang, Y., & Hu, X. (2011) · Oncogene · doi:10.1038/onc.2011.137 · Cited by 515 · see citing works

One-carbon metabolism in cancer

Newman, A. C., & Maddocks, O. D. K. (2017) · British Journal of Cancer · doi:10.1038/bjc.2017.118 · Cited by 511 · see citing works

Lactate Contribution to the Tumor Microenvironment: Mechanisms, Effects on Immune Cells and Therapeutic Relevance

Romero‐Garcia, S., Moreno‐Altamirano, M. M. B., Prado-Garcı́a, H., & Sánchez‐García, F. J. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00052 · Cited by 508 · see citing works

2nd ESMO Consensus Conference on Lung Cancer: early-stage non-small-cell lung cancer consensus on diagnosis, treatment and follow-up

Vansteenkiste, J., Crinò, L., Dooms, C., Douillard, J.-Y., Finn, C. F., Lim, E. K. S., Rocco, G., Senan, S., Schil, P. E. V., Veronesi, G., et al. (2014) · Annals of Oncology · doi:10.1093/annonc/mdu089 · Cited by 492 · see citing works

Glucose transporters: expression, regulation and cancer

MEDINA, R. A., & OWEN, G. I. (2002) · Biological Research · doi:10.4067/s0716-97602002000100004 · Cited by 472 · see citing works

Serine Catabolism Regulates Mitochondrial Redox Control during Hypoxia

Ye, J., Fan, J., Venneti, S., Wan, Y.-W., Pawel, B. R., Zhang, J., Finley, L. W. S., Lu, C., Lindsten, T., Cross, J. R., et al. (2014) · Cancer Discovery · doi:10.1158/2159-8290.cd-14-0250 · Cited by 452 · see citing works

2-Deoxy- d -glucose Increases the Efficacy of Adriamycin and Paclitaxel in Human Osteosarcoma and Non-Small Cell Lung Cancers In Vivo

Maschek, G., Savaraj, N., Priebe, W., Braunschweiger, P. G., Hamilton, K., Tidmarsh, G. F., Young, L. R. D., & Lampidis, T. J. (2004) · Cancer Research · doi:10.1158/0008-5472.can-03-3294 · Cited by 452 · see citing works

Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth

Clem, B. F., Telang, S., Clem, A. L., Yalçın, A., Meier, J. B., Simmons, A. J., Rasku, M. A., Arumugam, S., Dean, W. L., Eaton, J. W., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-07-0482 · Cited by 430 · see citing works

Activation of the HIF pathway in cancer

Maxwell, P. H. (2001) · Current Opinion in Genetics & Development · doi:10.1016/s0959-437x(00)00193-3 · Cited by 426 · see citing works

Mitochondria as biosynthetic factories for cancer proliferation

Ahn, C. S., & Metallo, C. M. (2015) · Cancer & Metabolism · doi:10.1186/s40170-015-0128-2 · Cited by 399 · see citing works

Warburg effect in chemosensitivity: Targeting lactate dehydrogenase-A re-sensitizes Taxol-resistant cancer cells to Taxol

Zhou, M., Zhao, Y., Ding, Y., Liu, H., Liu, Z., Fodstad, Ø., Riker, A. I., Kamarajugadda, S., Lu, J., Owen, L. B., et al. (2010) · Molecular Cancer · doi:10.1186/1476-4598-9-33 · Cited by 395 · see citing works

Metabolic Hallmarks of Tumor and Immune Cells in the Tumor Microenvironment

Renner, K., Singer, K., Koehl, G. E., Geissler, E. K., Peter, K., Siska, P. J., & Kreutz, M. P. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00248 · Cited by 378 · see citing works

Targeting glucose metabolism for cancer therapy

Hamanaka, R. B., & Chandel, N. S. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20120162 · Cited by 371 · see citing works

Regional glutamine deficiency in tumours promotes dedifferentiation through inhibition of histone demethylation

Pan, M., Reid, M. A., Lowman, X. H., Kulkarni, R. P., Tran, T. Q., Liu, X., Yang, Y., Hernandez-Davies, J. E., Rosales, K. K., Li, H., et al. (2016) · Nature Cell Biology · doi:10.1038/ncb3410 · Cited by 368 · see citing works

Clinical significance of ras oncogene activation in human lung cancer

Therapy, E. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90536-7 · Cited by 361 · see citing works

Global Regulation of Nucleotide Biosynthetic Genes by c-Myc

Liu, Y.-C., Li, F., Handler, J., Huang, C. R. L., Xiang, Y., Neretti, N., Sedivy, J. M., Zeller, K. I., & Dang, C. V. (2008) · PLoS ONE · doi:10.1371/journal.pone.0002722 · Cited by 317 · see citing works

Mitochondrial Phosphoenolpyruvate Carboxykinase Regulates Metabolic Adaptation and Enables Glucose-Independent Tumor Growth

Vincent, E. E., Sergushichev, A., Griss, T., Gingras, M., Samborska, B., Ntimbane, T., Coelho, P. P., Blagih, J., Raissi, T. C., Choinière, L., et al. (2015) · Molecular Cell · doi:10.1016/j.molcel.2015.08.013 · Cited by 278 · see citing works

O-GlcNAcylation in Cancer Biology: Linking Metabolism and Signaling

Ferrer, C. M., Sodi, V. L., & Reginato, M. J. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.05.028 · Cited by 268 · see citing works

Contribution of serine, folate and glycine metabolism to the ATP, NADPH and purine requirements of cancer cells

Tedeschi, P. M., Markert, E. K., Gounder, M. K., Lin, H., Dvorzhinski, D., Dolfi, S. C., Chan, L. L.-Y., Qiu, J., DiPaola, R. S., Hirshfield, K. M., et al. (2013) · Cell Death and Disease · doi:10.1038/cddis.2013.393 · Cited by 261 · see citing works

O-GlcNAcylation is a novel regulator of lung and colon cancer malignancy

Mi, W., Gu, Y., Han, C., Liu, H., Fan, Q., Zhang, X., Cong, Q., & Yu, W. (2011) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2011.01.009 · Cited by 259 · see citing works

The mitochondrial voltage-dependent anion channel 1 in tumor cells

Shoshan‐Barmatz, V., Ben-Hail, D., Admoni, L., Krelin, Y., & Tripathi, S. S. (2014) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2014.10.040 · Cited by 245 · see citing works

Quinoline 3-sulfonamides inhibit lactate dehydrogenase A and reverse aerobic glycolysis in cancer cells

Billiard, J., Dennison, J. B., Briand, J., Annan, R. S., Chai, D., Colón, M., Dodson, C. S., Gilbert, S. A., Greshock, J. D., Jing, J., et al. (2013) · Cancer & Metabolism · doi:10.1186/2049-3002-1-19 · Cited by 242 · see citing works

Phase 1 trial of dichloroacetate (DCA) in adults with recurrent malignant brain tumors

Dunbar, E. M., Coats, B. S., Shroads, A. L., Langaee, T., Lew, A., Forder, J. R., Shuster, J. J., Wagner, D. A., & Stacpoole, P. W. (2014) · Investigational New Drugs · doi:10.1007/s10637-013-0047-4 · Cited by 241 · see citing works

The Role of PET Scan in Diagnosis, Staging, and Management of Non-Small Cell Lung Cancer

Schrevens, L., Lorent, N., Dooms, C., & Vansteenkiste, J. (2004) · The Oncologist · doi:10.1634/theoncologist.9-6-633 · Cited by 239 · see citing works

Differential utilization of ketone bodies by neurons and glioma cell lines: a rationale for ketogenic diet as experimental glioma therapy

Maurer, G. D., Brucker, D. P., Bähr, O., Harter, P. N., Hattingen, E., Walenta, S., Mueller‐Klieser, W., Steinbach, J. P., & Rieger, J. (2011) · BMC Cancer · doi:10.1186/1471-2407-11-315 · Cited by 236 · see citing works

Pyruvate kinase M2-specific siRNA induces apoptosis and tumor regression

Goldberg, M. S., & Sharp, P. A. (2012) · The Journal of Experimental Medicine · doi:10.1084/jem.20111487 · Cited by 232 · see citing works

[18F]FDG Uptake and PCNA, Glut-1, and Hexokinase-II Expressions in Cancers and Inflammatory Lesions of the Lung

Mamede, M. H., Higashi, T., Kitaichi, M., Ishizu, K., Ishimori, T., Nakamoto, Y., Yanagihara, K., Li, M., Tanaka, F., Wada, H., et al. (2005) · Neoplasia · doi:10.1593/neo.04577 · Cited by 231 · see citing works

Insulin, the insulin-like growth factor axis, and mortality in patients with nonmetastatic colorectal cancer.

Wolpin, B. M., Meyerhardt, J. A., Chan, A. T., Ng, K., Chan, J. A., Wu, K., Pollak, M. N., Giovannucci, E. L., & Fuchs, C. S. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.17.9945 · Cited by 231 · see citing works

Mutant Isocitrate Dehydrogenase Inhibitors as Targeted Cancer Therapeutics

Golub, D., Iyengar, N. S., Dogra, S., Wong, T., Bready, D., Tang, K., Modrek, A. S., & Placantonakis, D. G. (2019) · Frontiers in Oncology · doi:10.3389/fonc.2019.00417 · Cited by 231 · see citing works

Nutrient scavenging in cancer

Finicle, B. T., Jayashankar, V., & Edinger, A. L. (2018) · Nature reviews. Cancer · doi:10.1038/s41568-018-0048-x · Cited by 228 · see citing works

Association Between Hyperglycemia and Survival in Patients With Newly Diagnosed Glioblastoma

Derr, R. L., Ye, X., Islas, M. U., Desideri, S., Saudek, C. D., & Grossman, S. A. (2009) · Journal of Clinical Oncology · doi:10.1200/jco.2008.19.1098 · Cited by 225 · see citing works

Cracking the O-GlcNAc code in metabolism

Ruan, H., Singh, J. P., Li, M., Wu, J., & Yang, X. (2013) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2013.02.002 · Cited by 224 · see citing works

Waves of gene regulation suppress and then restore oxidative phosphorylation in cancer cells

Smolková, K., Plecitá‐Hlavatá, L., Bellancé, N., Bénard, G., Rossignol, R., & Ježek, P. (2010) · The International Journal of Biochemistry & Cell Biology · doi:10.1016/j.biocel.2010.05.003 · Cited by 224 · see citing works

Is cancer a disease of abnormal cellular metabolism? New angles on an old idea

DeBerardinis, R. J. (2008) · Genetics in Medicine · doi:10.1097/gim.0b013e31818b0d9b · Cited by 217 · see citing works

Correlation of Glut-1 glucose transporter expression with [18F]FDG uptake in non-small cell lung cancer

Higashi, K., Ueda, Y., Sakurai, A., MingWang, X., Xu, L., Murakami, M., Seki, H., Oguchi, M., Taki, S., Nambu, Y., et al. (2000) · European Journal of Nuclear Medicine · doi:10.1007/s002590000367 · Cited by 210 · see citing works

Lonidamine triggers apoptosis via a direct, Bcl-2-inhibited effect on the mitochondrial permeability transition pore

Ravagnan, L., Marzo, I., Costantini, P., Susín, S. A., Zamzami, N., Petit, P. X., Hirsch, F., Goulbern, M., Poupon, M., Miccoli, L., et al. (1999) · Oncogene · doi:10.1038/sj.onc.1202625 · Cited by 207 · see citing works

Greater cell cycle inhibition and cytotoxicity induced by 2-deoxy-d-glucose in tumor cells treated under hypoxic vs aerobic conditions

Maher, J. C., Krishan, A., & Lampidis, T. J. (2004) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-003-0724-7 · Cited by 204 · see citing works

PCK2 activation mediates an adaptive response to glucose depletion in lung cancer

Leithner, K., Hrzenjak, A., Trötzmüller, M., Moustafa, T., Köfeler, H. C., Wohlkoenig, C., Stacher, E., Lindenmann, J., Harris, A. L., Olschewski, A., et al. (2014) · Oncogene · doi:10.1038/onc.2014.47 · Cited by 201 · see citing works

A Functional Screen for Myc-Responsive Genes Reveals Serine Hydroxymethyltransferase, a Major Source of the One-Carbon Unit for Cell Metabolism

Nikiforov, M. A., Chandriani, S. J., O’Connell, B. C., Petrenko, O., Kotenko, I., Beavis, A. J., Sedivy, J. M., & Cole, M. D. (2002) · Molecular and Cellular Biology · doi:10.1128/mcb.22.16.5793-5800.2002 · Cited by 201 · see citing works

FDG uptake, tumour characteristics and response to therapy

Smith, T. (1998) · Nuclear Medicine Communications · doi:10.1097/00006231-199802000-00002 · Cited by 200 · see citing works

PTEN deficiency and AMPK activation promote nutrient scavenging and anabolism in prostate cancer cells

Kim, S. M., Nguyen, T. T., Ravi, A., Kubiniok, P., Finicle, B. T., Jayashankar, V., Malacrida, L., Hou, J., Robertson, J., Gao, D., et al. (2018) · Cancer Discovery · doi:10.1158/2159-8290.cd-17-1215 · Cited by 199 · see citing works

A novel inhibitor of glucose uptake sensitizes cells to FAS-induced cell death

Wood, T. E., Dalili, S., Simpson, C. D., Hurren, R., Mao, X., Suárez, F., Gronda, M., Eberhard, Y., Minden, M. D., Bilan, P. J., et al. (2008) · Molecular Cancer Therapeutics · doi:10.1158/1535-7163.mct-08-0569 · Cited by 197 · see citing works

Sex differences in the association between diabetes and cancer: A systematic review and meta-analysis of 121 cohorts including 20 million individuals and one million events

Ohkuma, T., Peters, S. A. E., & Woodward, M. (2018) · Diabetologia · doi:10.1007/s00125-018-4664-5 · Cited by 188 · see citing works

Current Landscape of Targeted Therapy in Lung Cancer

Mayekar, M. K., & Bivona, T. G. (2017) · Clinical Pharmacology & Therapeutics · doi:10.1002/cpt.810 · Cited by 183 · see citing works

Aberrations of the p53 tumor suppressor gene in human non-small cell carcinomas of the lung

Kishimoto, Y., Murakami, Y., Shiraishi, M., Hayashi, K., & Sekiya, T. (1993) · Lung Cancer · doi:10.1016/0169-5002(93)90351-w · Cited by 177 · see citing works

Prognostic impact of cancer cachexia in patients with advanced non-small cell lung cancer

Kimura, M., Naito, T., Kenmotsu, H., Taira, T., Wakuda, K., Oyakawa, T., Hisamatsu, Y., Tokito, T., Imai, H., Akamatsu, H., et al. (2014) · Supportive Care in Cancer · doi:10.1007/s00520-014-2534-3 · Cited by 175 · see citing works

Genetic Disruption of Lactate/H+ Symporters (MCTs) and Their Subunit CD147/BASIGIN Sensitizes Glycolytic Tumor Cells to Phenformin

Marchiq, I., LeFloch, R., Roux, D., Simon, M., & Pouysségur, J. (2014) · Cancer Research · doi:10.1158/0008-5472.can-14-2260 · Cited by 175 · see citing works

Dietary Energy Restriction Modulates the Activity of AMP-Activated Protein Kinase, Akt, and Mammalian Target of Rapamycin in Mammary Carcinomas, Mammary Gland, and Liver

Jiang, W., Zhu, Z., & Thompson, H. J. (2008) · Cancer Research · doi:10.1158/0008-5472.can-07-6721 · Cited by 175 · see citing works

Metabolic changes in cancer: beyond the Warburg effect

Wu, W., & Zhao, S. (2013) · Acta Biochimica et Biophysica Sinica · doi:10.1093/abbs/gms104 · Cited by 173 · see citing works

Enasidenib: First Global Approval

Kim, E. (2017) · Drugs · doi:10.1007/s40265-017-0813-2 · Cited by 171 · see citing works

Physiological Effects of Chronic Hypoxia

West, J. B. (2017) · New England Journal of Medicine · doi:10.1056/nejmra1612008 · Cited by 169 · see citing works

Paclitaxel, cisplatin and lonidamine in advanced ovarian cancer. A phase II study

Lena, M. D., Lorusso, V., Latorre, A. C., Fanizza, G., Gargano, G., Caporusso, L., Guida, M., Catino, A., Crucitta, E., Sambiasi, D., et al. (2001) · European Journal of Cancer · doi:10.1016/s0959-8049(00)00400-7 · Cited by 168 · see citing works

One-carbon metabolism and nucleotide biosynthesis as attractive targets for anticancer therapy

Shuvalov, O., Petukhov, A., Daks, A., Fedorova, O., Vasileva, E., & Barlev, N. A. (2017) · Oncotarget · doi:10.18632/oncotarget.15053 · Cited by 168 · see citing works

Lonidamine: Efficacy and safety in clinical trials for the treatment of solid tumors

Cosimo, S. D., Ferretti, G., Papaldo, P., Carlini, P., Fabi, A., & Cognetti, F. (2003) · Drugs of today · doi:10.1358/dot.2003.39.3.799451 · Cited by 167 · see citing works

Anticancer Agents That Counteract Tumor Glycolysis

Granchi, C., & Minutolo, F. (2012) · ChemMedChem · doi:10.1002/cmdc.201200176 · Cited by 166 · see citing works

Glyoxalase in tumourigenesis and multidrug resistance

Thornalley, P. J., & Rabbani, N. (2011) · Seminars in Cell and Developmental Biology · doi:10.1016/j.semcdb.2011.02.006 · Cited by 163 · see citing works

Ivosidenib: First Global Approval

Dhillon, S. (2018) · Drugs · doi:10.1007/s40265-018-0978-3 · Cited by 163 · see citing works

Diabetogenic glucose and insulin concentrations modulate transcriptom and protein levels involved in tumour cell migration, adhesion and proliferation

Masur, K., Vetter, C., Hinz, A., Tomas, N. M., Henrich, H., Niggemann, B., & Zänker, K. S. (2010) · British Journal of Cancer · doi:10.1038/sj.bjc.6606050 · Cited by 153 · see citing works

Targeting Tumor Metabolism for Cancer Treatment: Is Pyruvate Dehydrogenase Kinases (PDKs) a Viable Anticancer Target?

Zhang, W., Zhang, S., Hu, X., & Tam, K. Y. (2015) · International Journal of Biological Sciences · doi:10.7150/ijbs.13325 · Cited by 153 · see citing works

Therapeutic targeting of PFKFB3 with a novel glycolytic inhibitor PFK158 promotes lipophagy and chemosensitivity in gynecologic cancers

Mondal, S., Roy, D., Bhattacharya, S. S., Jin, L., Jung, D., Zhang, S., Kalogera, E., Staub, J. K., Wang, Y., Xuyang, W., et al. (2018) · International Journal of Cancer · doi:10.1002/ijc.31868 · Cited by 153 · see citing works

3-bromopyruvate: Targets and outcomes

Shoshan, M. C. (2012) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-012-9419-2 · Cited by 144 · see citing works

Tumour microenvironment factors shaping the cancer metabolism landscape

Anastasiou, D. (2016) · British Journal of Cancer · doi:10.1038/bjc.2016.412 · Cited by 136 · see citing works

Targeting the RAS oncogene

Takashima, A., & Faller, D. V. (2013) · Expert Opinion on Therapeutic Targets · doi:10.1517/14728222.2013.764990 · Cited by 135 · see citing works

Regulation of mammalian muscle type 6‐phosphofructo‐1‐kinase and its implication for the control of the metabolism

Sola‐Penna, M., Da Silva, D., Coelho, W. S., Marinho‐Carvalho, M. M., & Zancan, P. (2010) · IUBMB Life · doi:10.1002/iub.393 · Cited by 135 · see citing works

SHMT1 knockdown induces apoptosis in lung cancer cells by causing uracil misincorporation

Paone, A., Marani, M., Fiascarelli, A., Rinaldo, S., Giardina, G., Contestabile, R., Paiardini, A., & Cutruzzolà, F. (2014) · Cell Death and Disease · doi:10.1038/cddis.2014.482 · Cited by 129 · see citing works

The bioenergetics of cancer: Is glycolysis the main ATP supplier in all tumor cells?

Moreno‐Sánchez, R., Rodríguez‐Enríquez, S., Saavedra, E., Marín‐Hernández, Á., & Gallardo‐Pérez, J. C. (2009) · BioFactors · doi:10.1002/biof.31 · Cited by 128 · see citing works

Glutamine Addiction and Therapeutic Strategies in Lung Cancer

Vanhove, K., Derveaux, E., Graulus, G., Mesotten, L., Thomeer, M., Noben, J., Guedens, W., & Adriaensens, P. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20020252 · Cited by 128 · see citing works

A Novel Lactate Dehydrogenase Inhibitor, 1-(Phenylseleno)-4-(Trifluoromethyl) Benzene, Suppresses Tumor Growth through Apoptotic Cell Death

Kim, E.-Y., Chung, T., Han, C. W., Park, M.-J., Park, K. H., Jang, S. B., & Ha, K. (2019) · Scientific Reports · doi:10.1038/s41598-019-40617-3 · Cited by 127 · see citing works

The apple polyphenol phloretin inhibits breast cancer cell migration and proliferation via inhibition of signals by type 2 glucose transporter

Wu, K.-H., Ho, C., Chen, Z.-F., Chen, L.-C., Whang‐Peng, J., Lin, T., & Ho, Y. (2017) · Journal of Food and Drug Analysis · doi:10.1016/j.jfda.2017.03.009 · Cited by 126 · see citing works

Molecular Pathways: Targeting Cellular Energy Metabolism in Cancer via Inhibition of SLC2A1 and LDHA

Ooi, A. T., & Gomperts, B. N. (2015) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-14-1209 · Cited by 122 · see citing works

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance

Hirpara, J. L., Eu, J. Q., Tan, J. K. M., Wong, A. L., Clement, M., Kong, L. R., Ohi, N., Tsunoda, T., Qu, J., Goh, B. C., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101076 · Cited by 122 · see citing works

The Glycolytic Inhibitor 2-Deoxyglucose Activates Multiple Prosurvival Pathways through IGF1R

Zhong, D., Xiong, L., Liu, T., Liu, X., Liu, X., Chen, J., Sun, S., Khuri, F. R., Zong, Y., Zhou, Q., et al. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.005280 · Cited by 121 · see citing works

The Emerging Facets of Non-Cancerous Warburg Effect

Abdel‐Haleem, A. M., Lewis, N. E., Jamshidi, N., Mineta, K., Gao, X., & Gojobori, T. (2017) · Frontiers in Endocrinology · doi:10.3389/fendo.2017.00279 · Cited by 121 · see citing works

Reviving Lonidamine and 6-Diazo-5-oxo-L-norleucine to Be Used in Combination for Metabolic Cancer Therapy

Cervantes-Madrid, D., Romero, Y., & Dueñas‐González, A. (2015) · BioMed Research International · doi:10.1155/2015/690492 · Cited by 119 · see citing works

O-GlcNAcylation and Metabolic Reprograming in Cancer

Åowiak, P. J., Forma, E., Bryś, M., & Krześlak, A. (2014) · Frontiers in Endocrinology · doi:10.3389/fendo.2014.00145 · Cited by 119 · see citing works

The assessment and impact of sarcopenia in lung cancer: a systematic literature review

Collins, J., Noble, S., Chester, J. D., Coles, B., & Byrne, A. (2014) · BMJ Open · doi:10.1136/bmjopen-2013-003697 · Cited by 118 · see citing works

Nonoxidative pentose phosphate pathways and their direct role in ribose synthesis in tumors: is cancer a disease of cellular glucose metabolism?

Boros, L. G., Lee, P. W. N., Brandes, J. L., Cascante, M., Muscarella, P., Schirmer, W. J., Melvin, W. S., & Ellison, E. C. (1998) · Medical Hypotheses · doi:10.1016/s0306-9877(98)90178-5 · Cited by 111 · see citing works

Altered Glutamine Metabolism and Therapeutic Opportunities for Lung Cancer

Mohamed, A., Deng, X., Khuri, F. R., & Owonikoko, T. K. (2013) · Clinical Lung Cancer · doi:10.1016/j.cllc.2013.09.001 · Cited by 111 · see citing works

Hexokinase II inhibitor, 3-BrPA induced autophagy by stimulating ROS formation in human breast cancer cells

Zhang, Q., Zhang, Y., Zhang, P., 晁振华, Xia, F., Jiang, C., Zhang, X., Jiang, Z., & Liu, H. (2014) · Genes & Cancer · doi:10.18632/genesandcancer.9 · Cited by 94 · see citing works

Glyceraldehyde-3-Phosphate Dehydrogenase: A Promising Target for Molecular Therapy in Hepatocellular Carcinoma

Ganapathy‐Kanniappan, S., Kunjithapatham, R., & Geschwind, J.-F. H. (2012) · Oncotarget · doi:10.18632/oncotarget.623 · Cited by 88 · see citing works

AZD7545 is a selective inhibitor of pyruvate dehydrogenase kinase 2

Morrell, J., Orme, J. P., Butlin, R. J., Roche, T. E., Mayers, R. M., & Kilgour, E. (2003) · Biochemical Society Transactions · doi:10.1042/bst0311168 · Cited by 86 · see citing works

Glycosylation Alterations in Lung and Brain Cancer

Lemjabbar‐Alaoui, H., McKinney, A., Yang, Y., Tran, V. M., & Phillips, J. J. (2015) · Advances in cancer research · doi:10.1016/bs.acr.2014.11.007 · Cited by 85 · see citing works

Time to Progression in Metastatic Breast Cancer Patients Treated With Epirubicin Is Not Improved by the Addition of Either Cisplatin or Lonidamine: Final Results of a Phase III Study With a Factorial Design

Berruti, A., Bitossi, R., Gorzegno, G., Bottini, A., Alquati, P., Matteis, A. D., Nuzzo, F., Giardina, G., Danese, S., Lena, M. D., et al. (2002) · Journal of Clinical Oncology · doi:10.1200/jco.2002.08.012 · Cited by 84 · see citing works

VDAC1 is a molecular target in glioblastoma, with its depletion leading to reprogrammed metabolism and reversed oncogenic properties

Arif, T., Krelin, Y., Nakdimon, I., Benharroch, D., Paul, A., Dadon-Klein, D., & Shoshan‐Barmatz, V. (2016) · Neuro-Oncology · doi:10.1093/neuonc/now297 · Cited by 84 · see citing works

Anticancer efficacy of the metabolic blocker 3-bromopyruvate: specific molecular targeting.

Ganapathy‐Kanniappan, S., Kunjithapatham, R., & Geschwind, J.-F. H. (2013) · PubMed · Cited by 76 · see citing works

High Expression of PHGDH Predicts Poor Prognosis in Non–Small Cell Lung Cancer

Zhu, J., Ma, J., Wang, X., Ma, T., Zhang, S., Wang, W., Zhou, X., & Shi, J. (2016) · Translational Oncology · doi:10.1016/j.tranon.2016.08.003 · Cited by 75 · see citing works

The anticancer agent 3-bromopyruvate: a simple but powerful molecule taken from the lab to the bedside

Azevedo‐Silva, J., Queirós, O., Baltazar, F., Ułaszewski, S., Goffeau, A., Ko, Y. H., Pedersen, P. L., Preto, A., & Casal, M. (2016) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-016-9670-z · Cited by 74 · see citing works

Detection of Lung Cancer through Metabolic Changes Measured in Blood Plasma

Louis, E., Adriaensens, P., Guedens, W., Bigirumurame, T., Baeten, K., Vanhove, K., Vandeurzen, K., Darquennes, K., Vansteenkiste, J., Dooms, C., et al. (2016) · Journal of Thoracic Oncology · doi:10.1016/j.jtho.2016.01.011 · Cited by 73 · see citing works

Association of glyceraldehyde-3-phosphate dehydrogenase expression with cell motility and metastatic potential of rat prostatic adenocarcinoma.

Epner, D. E., Partin, A. W., Schalken, J. A., Isaacs, J. T., & Coffey, D. S. (1993) · PubMed · Cited by 69 · see citing works

Reciprocal Regulation of Metabolic Reprogramming and Epigenetic Modifications in Cancer

Yu, X., Ma, R., Wu, Y., Zhai, Y., & Li, S. (2018) · Frontiers in Genetics · doi:10.3389/fgene.2018.00394 · Cited by 61 · see citing works

Cell Active Hydroxylactam Inhibitors of Human Lactate Dehydrogenase with Oral Bioavailability in Mice

Purkey, H. E., Robarge, K. D., Chen, J., Chen, Z., Corson, L., Ding, C. Z., DiPasquale, A. G., Dragovich, P. S., Eigenbrot, C. W., Evangelista, M., et al. (2016) · ACS Medicinal Chemistry Letters · doi:10.1021/acsmedchemlett.6b00190 · Cited by 60 · see citing works

Molecular Pathology of Non-Small-Cell Lung Cancer

Breuer, R. H. J., Postmus, P. E., & Smit, E. F. (2005) · Respiration · doi:10.1159/000085376 · Cited by 58 · see citing works

Mitochondrial VDAC1 Silencing Leads to Metabolic Rewiring and the Reprogramming of Tumour Cells into Advanced Differentiated States

Arif, T., Paul, A., Krelin, Y., Shteinfer‐Kuzmine, A., & Shoshan‐Barmatz, V. (2018) · Cancers · doi:10.3390/cancers10120499 · Cited by 55 · see citing works

Glyceraldehyde 3-Phosphate Dehydrogenase Depletion Induces Cell Cycle Arrest and Resistance to Antimetabolites in Human Carcinoma Cell Lines

Phadke, M. S., Krynetskaia, N. F., Mishra, A. K., & Krynetskiy, E. Y. (2009) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.109.155671 · Cited by 51 · see citing works

Effect of 3-bromopyruvate acid on the redox equilibrium in non-invasive MCF-7 and invasive MDA-MB-231 breast cancer cells

Kwiatkowska, E., Wojtala, M., Gajewska, A., Soszyński, M., Bartosz, G., & Sadowska‐Bartosz, I. (2015) · Journal of Bioenergetics and Biomembranes · doi:10.1007/s10863-015-9637-5 · Cited by 50 · see citing works

Glycine Decarboxylase Activity Drives Non-Small Cell Lung Cancer Tumor-Initiating Cells and Tumorigenesis

Zhang, W. C., Shyh‐Chang, N., He, Y., Rai, A., Umashankar, S., Ma, S., Soh, B.-S., Sun, L. L., Tai, B. C., Nga, M. E., et al. (2012) · Cell · doi:10.1016/j.cell.2012.02.024 · Cited by 48 · see citing works

TKTL1 is overexpressed in a large portion of non-small cell lung cancer specimens

Schultz, H., Kähler, D., Branscheid, D., Vollmer, E., Zabel, P., & Goldmann, T. (2008) · Diagnostic Pathology · doi:10.1186/1746-1596-3-35 · Cited by 45 · see citing works

Differential 3-bromopyruvate inhibition of cytosolic and mitochondrial human serine hydroxymethyltransferase isoforms, key enzymes in cancer metabolic reprogramming

Paiardini, A., Tramonti, A., Schirch, D., Guiducci, G., di Salvo, M. L., Fiascarelli, A., Giorgi, A., Maras, B., Cutruzzolà, F., & Contestabile, R. (2016) · Biochimica et Biophysica Acta (BBA) - Proteins and Proteomics · doi:10.1016/j.bbapap.2016.08.010 · Cited by 44 · see citing works

Metabolic Plasiticy in Cancers—Distinct Role of Glycolytic Enzymes GPI, LDHs or Membrane Transporters MCTs

Ždralević, M., Marchiq, I., de Padua, M. M. C., Parks, S. K., & Pouysségur, J. (2017) · Frontiers in Oncology · doi:10.3389/fonc.2017.00313 · Cited by 43 · see citing works

Novel N-phenyl dichloroacetamide derivatives as anticancer reagents: Design, synthesis and biological evaluation

Yang, Y.-C., Shang, P., Cheng, C., Wang, D., Yang, P., Zhang, F., Li, T., Lu, A., & Zhao, Y. (2010) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2010.06.032 · Cited by 42 · see citing works

Metabolic Reprograming Via Silencing of Mitochondrial VDAC1 Expression Encourages Differentiation of Cancer Cells

Arif, T., Amsalem, Z., & Shoshan‐Barmatz, V. (2019) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2019.05.003 · Cited by 42 · see citing works

Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression

Davies, P. C. W., Demetrius, L., & Tuszyński, J. A. (2012) · AIP Advances · doi:10.1063/1.3697850 · Cited by 39 · see citing works

DNA Methylation and Nonsmall Cell Lung Cancer

Lu, F. Y., & Zhang, H. (2011) · The Anatomical Record · doi:10.1002/ar.21471 · Cited by 39 · see citing works

Quantitative Proteomic Approach to Understand Metabolic Adaptation in Non-Small Cell Lung Cancer

Martín-Bernabé, A., Cortés, R., Lehmann, S. G., Seve, M., Cascante, M., & Bourgoin‐Voillard, S. (2014) · Journal of Proteome Research · doi:10.1021/pr500327v · Cited by 35 · see citing works

Enhancing anticancer effects, decreasing risks and solving practical problems facing 3-bromopyruvate in clinical oncology: 10 years of research experience

Sayed, S. M. E. (2018) · International Journal of Nanomedicine · doi:10.2147/ijn.s170564 · Cited by 33 · see citing works

Phase III trial with and without lonidamine in non-small cell lung cancer.

Gatzemeier, U., Cavalli, F., Häussinger, K., Kaukel, E., Koschel, G., Martinelli, G., Neuhauss, R., & von Pawel, J. (1991) · PubMed · Cited by 29 · see citing works

Synergistic antitumor effect of 3-bromopyruvate and 5-fluorouracil against human colorectal cancer through cell cycle arrest and induction of apoptosis

Chong, D., Ma, L., Liu, F., Zhang, Z., Zhao, S., Huo, Q., Zhang, P., Zheng, H., & Liu, H. (2017) · Anti-Cancer Drugs · doi:10.1097/cad.0000000000000517 · Cited by 29 · see citing works

13C MRS and LC–MS Flux Analysis of Tumor Intermediary Metabolism

Shestov, A. A., Lee, S., Nath, K., Guo, L., NELSON, D. S., Roman, J. C., Leeper, D. B., Wasik, M. A., Blair, I. A., & Glickson, J. D. (2016) · Frontiers in Oncology · doi:10.3389/fonc.2016.00135 · Cited by 28 · see citing works

Identifying Causes for Excess Mortality in Patients With Diabetes: Closer but Not There Yet

Yu, O. H. Y., & Suissa, S. (2016) · Diabetes Care · doi:10.2337/dci16-0026 · Cited by 28 · see citing works

Non–small cell lung cancers with isocitrate dehydrogenase 1 or 2 ( IDH1/2 ) mutations

Toth, L. N., Abreu, F. B. D., & Tafe, L. J. (2018) · Human Pathology · doi:10.1016/j.humpath.2018.04.014 · Cited by 28 · see citing works

TKTL-1 expression in lung cancer

Fritz, P., Coy, J. F., Mürdter, T. E., Ott, G., Alscher, M. D., & Friedel, G. (2012) · Pathology - Research and Practice · doi:10.1016/j.prp.2012.01.007 · Cited by 27 · see citing works

A novel small-molecule inhibitor of 3-phosphoglycerate dehydrogenase

Mullarky, E., Lairson, L. L., Cantley, L. C., & Lyssiotis, C. A. (2016) · Molecular & Cellular Oncology · doi:10.1080/23723556.2016.1164280 · Cited by 27 · see citing works

PEPCK in cancer cell starvation

Leithner, K. (2015) · Oncoscience · doi:10.18632/oncoscience.252 · Cited by 14 · see citing works

A Historical View of Overflow Metabolism

Vázquez, A. (2017) · Elsevier eBooks · doi:10.1016/b978-0-12-812208-2.00001-9 · Cited by 6 · see citing works

Phosphatidykinosital 3-Kinase and Mammalian Target of Rapamycin Pathway in Non–Small-Cell Lung Cancer

Massarelli, E., & Papadimitrakopoulou, V. A. (2012) · Journal of Thoracic Oncology · doi:10.1097/jto.0b013e31826df0f0 · Cited by 4 · see citing works

The oncogenic and clinical implications of lactate induced immunosuppression in the tumour microenvironment

Hayes, C., Donohoe, C. L., Davern, M., & Donlon, N. E. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.12.021 · Cited by 215 · see citing works

Metabolic reprogramming of oncogene-addicted cancer cells to OXPHOS as a mechanism of drug resistance

Hirpara, J. L., Eu, J. Q., Tan, J. K. M., Wong, A. L., Clement, M., Kong, L. R., Ohi, N., Tsunoda, T., Qu, J., Goh, B. C., et al. (2018) · Redox Biology · doi:10.1016/j.redox.2018.101076 · Cited by 122 · see citing works

Lung cancer associated with combustion particles and fine particulate matter (PM2.5) - The roles of polycyclic aromatic hydrocarbons (PAHs) and the aryl hydrocarbon receptor (AhR)

Holme, J. A., Vondráček, J., Machala, M., Lagadic‐Gossmann, D., Vogel, C. F. A., Ferrec, E. L., Sparfel, L., & Øvrevik, J. (2023) · Biochemical Pharmacology · doi:10.1016/j.bcp.2023.115801 · Cited by 113 · see citing works

Metformin in Combination With Chemoradiotherapy in Locally Advanced Non–Small Cell Lung Cancer

Tsakiridis, T. K., Pond, G. R., Wright, J., Ellis, P. M., Ahmed, N., Abdulkarim, B., Roa, W., Robinson, A. G., Swaminath, A., Okawara, G. S., et al. (2021) · JAMA Oncology · doi:10.1001/jamaoncol.2021.2328 · Cited by 114 · see citing works

Current Progresses and Challenges of Immunotherapy in Triple-Negative Breast Cancer

Mediratta, K., El‐Sahli, S., D’Costa, V. M., & Wang, L. (2020) · Cancers · doi:10.3390/cancers12123529 · Cited by 102 · see citing works

Circular RNA circCUL3 Accelerates the Warburg Effect Progression of Gastric Cancer through Regulating the STAT3/HK2 Axis

Pu, Z., Xu, M., Yuan, X., Xie, H., & Zhao, J. (2020) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2020.08.023 · Cited by 82 · see citing works

TRIM46 activates AKT/HK2 signaling by modifying PHLPP2 ubiquitylation to promote glycolysis and chemoresistance of lung cancer cells

Tantai, J., Pan, X., Chen, Y., Shen, Y., & Ji, C. (2022) · Cell Death and Disease · doi:10.1038/s41419-022-04727-7 · Cited by 71 · see citing works

Notch1/TAZ axis promotes aerobic glycolysis and immune escape in lung cancer

Xie, M., Fu, X., & Jiang, K. (2021) · Cell Death and Disease · doi:10.1038/s41419-021-04124-6 · Cited by 68 · see citing works

Understanding glycosylation: Regulation through the metabolic flux of precursor pathways

Scheper, A. F., Schofield, J., Bohara, R. A., Ritter, T., & Pandit, A. S. (2023) · Biotechnology Advances · doi:10.1016/j.biotechadv.2023.108184 · Cited by 68 · see citing works

The strategic roles of four enzymes in the interconnection between metabolism and oncogene activation in non-small cell lung cancer: Therapeutic implications

Icard, P., Simula, L., Fournel, L., Leroy, K., Mansuet‐Lupo, A., Damotte, D., Charpentier, M.-C., Durdux, C., Loi, M., Schussler, O., et al. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100852 · Cited by 63 · see citing works

Prognostic Implication of a Metabolism-Associated Gene Signature in Lung Adenocarcinoma

He, L., Chen, J., Xu, F., Li­, ­., & Li, J. (2020) · Molecular Therapy — Oncolytics · doi:10.1016/j.omto.2020.09.011 · Cited by 61 · see citing works

3D plasmonic hexaplex paper sensor for label-free human saliva sensing and machine learning-assisted early-stage lung cancer screening

Linh, V. T. N., Kim, H., Lee, M., Mun, J., Kim, Y., Jeong, B., Park, S., Kim, D., Rho, J., & Jung, H. S. (2023) · Biosensors and Bioelectronics · doi:10.1016/j.bios.2023.115779 · Cited by 62 · see citing works

Harnessing mitochondrial metabolism and drug resistance in non-small cell lung cancer and beyond by blocking heat-shock proteins

Parma, B., Wurdak, H., & Ceppi, P. (2022) · Drug Resistance Updates · doi:10.1016/j.drup.2022.100888 · Cited by 58 · see citing works

Link of sorafenib resistance with the tumor microenvironment in hepatocellular carcinoma: Mechanistic insights

Tian, X., Yan, T., Liu, F., Liu, Q., Zhao, J., Xiong, H., & Jiang, S. (2022) · Frontiers in Pharmacology · doi:10.3389/fphar.2022.991052 · Cited by 53 · see citing works

Targeting Glucose Metabolism in Cancer Cells as an Approach to Overcoming Drug Resistance

Cunha, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2023) · Pharmaceutics · doi:10.3390/pharmaceutics15112610 · Cited by 56 · see citing works

Metabolic Reprogramming in Lung Cancer: Hallmarks, Mechanisms, and Targeted Strategies to Overcome Immune Resistance

Chen, Y., Bai, M., Liu, M., Zhang, Z., Jiang, C., Li, K., Chen, Y., Xu, Y., & Wu, L. (2025) · Cancer Medicine · doi:10.1002/cam4.71317 · Cited by 52 · see citing works

Association of Metabolic Syndrome With Risk of Lung Cancer

Li, M., Cao, S., Dimou, N. L., Wu, L., Li, J., & Yang, J. (2023) · CHEST Journal · doi:10.1016/j.chest.2023.08.003 · Cited by 49 · see citing works

lncRNA GAS6-AS1 inhibits progression and glucose metabolism reprogramming in LUAD via repressing E2F1-mediated transcription of GLUT1

Luo, J., Wang, H., Wang, L., Wang, G., Yao, Y., Xie, K., Li, X., Xu, L., Shen, Y., & Ren, B. (2021) · Molecular Therapy — Nucleic Acids · doi:10.1016/j.omtn.2021.04.022 · Cited by 48 · see citing works

Non-Coding RNAs in Lung Tumor Initiation and Progression

Santos, R. M., Moreno, C., & Zhang, W. C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21082774 · Cited by 48 · see citing works

Targeting cancer-specific metabolic pathways for developing novel cancer therapeutics

Pal, S., Sharma, A. K., Mathew, S. P., & Jaganathan, B. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.955476 · Cited by 49 · see citing works

Combined inhibition of pyruvate dehydrogenase kinase 1 and lactate dehydrogenase a induces metabolic and signaling reprogramming and enhances lung adenocarcinoma cell killing

Zhou, Y., Guo, Y., Ran, M., Shan, W., Granchi, C., Giovannetti, E., Minutolo, F., Peters, G. J., & Tam, K. Y. (2023) · Cancer Letters · doi:10.1016/j.canlet.2023.216425 · Cited by 44 · see citing works

Activity-Based Self-Enriched SERS Sensor for Blood Metabolite Monitoring

Cai, C., Liu, Y., Zhang, Z., Tian, T., Wang, Y., Wang, L., Zhang, K., & Liu, B. (2023) · ACS Applied Materials & Interfaces · doi:10.1021/acsami.2c18261 · Cited by 42 · see citing works

Expression of proteins associated with the Warburg‐effect and survival in colorectal cancer

Offermans, K., Jenniskens, J. C. A., Simons, C. C. J. M., Samarska, I. V., Fazzi, G. E., Smits, K. M., Schouten, L. J., Weijenberg, M. P., Grabsch, H. I., & van den Brandt, P. A. (2021) · The Journal of Pathology Clinical Research · doi:10.1002/cjp2.250 · Cited by 41 · see citing works

Canagliflozin mediates tumor suppression alone and in combination with radiotherapy in non‐small cell lung cancer (NSCLC) through inhibition of HIF‐1α

Biziotis, O., Tsakiridis, E. E., Ali, A., Ahmadi, E., Wu, J., Wang, S. J. H., Mekhaeil, B., Singh, K., Menjolian, G., Farrell, T. J., et al. (2023) · Molecular Oncology · doi:10.1002/1878-0261.13508 · Cited by 42 · see citing works

2D versus 3D tumor-on-chip models to study the impact of tumor organization on metabolic patterns in vitro

Guerrero‐López, P., Martín-Pardillos, A., Bonet‐Aleta, J., Mosseri, A., Hueso, J. L., Santamarı́a, J., & García‐Aznar, J. M. (2025) · Scientific Reports · doi:10.1038/s41598-025-03504-8 · Cited by 43 · see citing works

Integrated bioinformatics analyses identifying key transcriptomes correlated with prognosis and immune infiltrations in lung squamous cell carcinoma

Alghamdi, R. A., & Al-Zahrani, M. H. (2023) · Saudi Journal of Biological Sciences · doi:10.1016/j.sjbs.2023.103596 · Cited by 39 · see citing works

Rapid diagnosis of malignant pleural mesothelioma and its discrimination from lung cancer and benign exudative effusions using blood serum

Yonar, D., Severcan, M., Gurbanov, R., Sandal, A., Yılmaz, Ü., Emri, S., & Severcan, F. (2022) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2022.166473 · Cited by 38 · see citing works

The mitochondrial Ca2+ channel MCU is critical for tumor growth by supporting cell cycle progression and proliferation

Fernández-García, E., Paudel, U., Noji, M., Bowman, C. E., Pitarresi, J. R., Rustgi, A. K., Wellen, K. E., Arany, Z. P., Weissenrieder, J., & Foskett, J. K. (2023) · Frontiers in Cell and Developmental Biology · doi:10.3389/fcell.2023.1082213 · Cited by 35 · see citing works

Role of glucose metabolic reprogramming in colorectal cancer progression and drug resistance

Qin, R., Fan, X., Huang, Y., Chen, S., Ding, R., Yao, Y., Wu, R., Duan, Y., Li, X., Khan, H. U., et al. (2024) · Translational Oncology · doi:10.1016/j.tranon.2024.102156 · Cited by 36 · see citing works

Activities against Lung Cancer of Biosynthesized Silver Nanoparticles: A Review

Mejía-Méndez, J. L., López-Mena, E. R., & Sánchez-Arreola, E. (2023) · Biomedicines · doi:10.3390/biomedicines11020389 · Cited by 37 · see citing works

Dihydroartemisinin and artesunate inhibit aerobic glycolysis via suppressing c-Myc signaling in non-small cell lung cancer

Zhang, Y., Wang, Y., Li, Y., Huang, C., Xiao, X., Zhong, Z., Tang, J., Lu, H., Tang, Y., & Yang, J. (2022) · Biochemical Pharmacology · doi:10.1016/j.bcp.2022.114941 · Cited by 35 · see citing works

Polysaccharides from Dendrobium officinale inhibit proliferation of osteosarcoma cells and enhance cisplatin-induced apoptosis

Zhang, X., Duan, S., Tao, S., Huang, J., Liu, C., Xing, S., Ren, Z., Lei, Z., Li, Y., & Wei, G. (2020) · Journal of Functional Foods · doi:10.1016/j.jff.2020.104143 · Cited by 35 · see citing works

Metabolic therapy and bioenergetic analysis: The missing piece of the puzzle

Duraj, T., Carrión-Navarro, J., Seyfried, T. N., Garcia‐Romero, N., & Ayuso‐Sacido, Á. (2021) · Molecular Metabolism · doi:10.1016/j.molmet.2021.101389 · Cited by 34 · see citing works

Integrated analysis of transcriptomic and metabolomic profiling reveal the p53 associated pathways underlying the response to ionizing radiation in HBE cells

Huang, R., Liu, X., Li, H., Zhou, Y., & Zhou, P. (2020) · Cell & Bioscience · doi:10.1186/s13578-020-00417-z · Cited by 32 · see citing works

Formosanin C inhibits non-small-cell lung cancer progression by blocking MCT4/CD147-mediated lactate export

Li, J., Wu, Z., Chen, G., Wang, X., Zhu, X., Zhang, Y., Zhang, R., Wu, W., Zhu, Y. Z., Ma, L., et al. (2022) · Phytomedicine · doi:10.1016/j.phymed.2022.154618 · Cited by 31 · see citing works

Targeting Lactate: An Emerging Strategy for Macrophage Regulation in Chronic Inflammation and Cancer

Jiang, R., Ren, W.-J., Wang, L., Zhang, W., Jiang, Z., & Zhu, G. (2024) · Biomolecules · doi:10.3390/biom14101202 · Cited by 29 · see citing works

Targeting glycolysis: exploring a new frontier in glioblastoma therapy

Yang, L., Li, S., Yu, L., Leng, J., & Li, N. (2025) · Frontiers in Immunology · doi:10.3389/fimmu.2024.1522392 · Cited by 28 · see citing works

Metabolomic Fingerprinting for the Detection of Early-Stage Lung Cancer: From the Genome to the Metabolome

Haince, J.-F., Joubert, P., Bach, H., Bux, R. A., Tappia, P. S., & Ramjiawan, B. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23031215 · Cited by 25 · see citing works

PRDX1 stimulates non-small-cell lung carcinoma to proliferate via the Wnt/β-Catenin signaling

Song, C., Xiong, G., Yang, S., Xiaoqun, W. E. I., Ye, X., Huang, W., & ZHANG, R. (2021) · Panminerva Medica · doi:10.23736/s0031-0808.20.03978-6 · Cited by 23 · see citing works

Automated detection and classification of tumor histotypes on dynamic PET imaging data through machine-learning driven voxel classification

Bianchetti, G., Taralli, S., Vaccaro, M., Indovina, L., Mattoli, M. V., Capotosti, A., Scolozzi, V., Calcagni, M. L., Giordano, A., Spirito, M. D., et al. (2022) · Computers in Biology and Medicine · doi:10.1016/j.compbiomed.2022.105423 · Cited by 23 · see citing works

20-Hydroxyecdysone Confers Antioxidant and Antineoplastic Properties in Human Non-Small Cell Lung Cancer Cells

Shuvalov, O., Kirdeeva, Y., Fefilova, E., Netsvetay, S., Zorin, M., Vlasova, Y., Fedorova, O., Daks, A., Parfenyev, S., & Barlev, N. (2023) · Metabolites · doi:10.3390/metabo13050656 · Cited by 21 · see citing works

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers

Cargill, K. R., Hasken, W. L., Gay, C. M., & Byers, L. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.757323 · Cited by 21 · see citing works

Glycolytic Inhibitors Potentiated the Activity of Paclitaxel and Their Nanoencapsulation Increased Their Delivery in a Lung Cancer Model

Cunha, A., Rocha, A. C., Barbosa, F., Baião, A., Silva, P. M. A., Sarmento, B. F. C. C., & Queirós, O. (2022) · Pharmaceutics · doi:10.3390/pharmaceutics14102021 · Cited by 21 · see citing works

Unravelling the Triad of Lung Cancer, Drug Resistance, and Metabolic Pathways

Mohanty, P., Pande, B., Acharya, R. K., Bhaskar, L. V., & Verma, H. K. (2024) · Diseases · doi:10.3390/diseases12050093 · Cited by 20 · see citing works

Metabolic shifts modulate lung injury caused by infection with H1N1 influenza A virus

Nolan, K. E., Baer, L. A., Karekar, P., Nelson, A. M., Stanford, K. I., Doolittle, L. M., Rosas, L. E., Hickman‐Davis, J. M., Singh, H., & Davis, I. C. (2021) · Virology · doi:10.1016/j.virol.2021.03.008 · Cited by 21 · see citing works

Changes in Metabolism as a Diagnostic Tool for Lung Cancer: Systematic Review

Mariën, H., Derveaux, E., Vanhove, K., Adriaensens, P., Thomeer, M., & Mesotten, L. (2022) · Metabolites · doi:10.3390/metabo12060545 · Cited by 19 · see citing works

Metabolomics and lipidomics in non-small cell lung cancer

Shi, W., Cheng, Y., Zhu, H., & Zhao, L. (2024) · Clinica Chimica Acta · doi:10.1016/j.cca.2024.117823 · Cited by 21 · see citing works

Metabolic Rewiring in Radiation Oncology Toward Improving the Therapeutic Ratio

van Gisbergen, M. W., Zwilling, E., & Dubois, L. J. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.653621 · Cited by 20 · see citing works

LPCAT1 promotes gefitinib resistance via upregulation of the EGFR/PI3K/AKT signaling pathway in lung adenocarcinoma

Ding, J., Ding, X., & Leng, Z. (2022) · Journal of Cancer · doi:10.7150/jca.66126 · Cited by 19 · see citing works

Network medicine in ovarian cancer: topological properties to drug discovery

Chirom, K., Malik, M. Z., Mangangcha, I. R., Somvanshi, P., & Singh, R. K. B. (2022) · Briefings in Bioinformatics · doi:10.1093/bib/bbac085 · Cited by 18 · see citing works

Impact of PET/CT Imaging with FDG in Locally Advanced Cervical Carcinoma—A Literature Review

Molnar, O., Straciuc, O. M., Mihuțiu, S., & Lazăr, L. (2024) · Current Oncology · doi:10.3390/curroncol31050188 · Cited by 17 · see citing works

Histone deacetylase inhibitor belinostat regulates metabolic reprogramming in killing KRAS‐mutant human lung cancer cells

Peter, R. M., Sarwar, M. S., Mostafa, S. Z., Wang, Y., Su, X., & Kong, A. T. (2023) · Molecular Carcinogenesis · doi:10.1002/mc.23551 · Cited by 16 · see citing works

A Novel Immune‐Related Gene Signature Predicts Prognosis of Lung Adenocarcinoma

Ma, C., Li, F., Wang, Z., & Luo, H. (2022) · BioMed Research International · doi:10.1155/2022/4995874 · Cited by 16 · see citing works

p53-independent effects of Set7/9 lysine methyltransferase on metabolism of non-small cell lung cancer cells

Daks, A., Shuvalov, O., Fedorova, O., Petukhov, A., Lezina, L., Zharova, A., Baidyuk, E., Khudiakov, A., & Barlev, N. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.706668 · Cited by 15 · see citing works

Identification of a six-gene metabolic signature predicting overall survival for patients with lung adenocarcinoma

Cao, Y., Lü, X., Li, Y., Fu, J., Li, H., Li, X., Chang, Z., & Liu, S. (2020) · PeerJ · doi:10.7717/peerj.10320 · Cited by 15 · see citing works

Detection of Lung Cancer via Blood Plasma and 1H-NMR Metabolomics: Validation by a Semi-Targeted and Quantitative Approach Using a Protein-Binding Competitor

Derveaux, E., Thomeer, M., Mesotten, L., Reekmans, G., & Adriaensens, P. (2021) · Metabolites · doi:10.3390/metabo11080537 · Cited by 15 · see citing works

Multi-modal Ca2+ nanogenerator via reversing T cell exhaustion for enhanced chemo-immunotherapy

An, J., Guo, R., Liu, M., Hu, H., & Zhang, H. (2024) · Journal of Controlled Release · doi:10.1016/j.jconrel.2024.06.066 · Cited by 15 · see citing works

New Insights on Old Biomarkers Involved in Tumor Microenvironment Changes and Their Diagnostic Relevance in Non-Small Cell Lung Carcinoma

Wadowska, K., Błasiak, P., Rzechonek, A., Bil‐Lula, I., & Śliwińska‐Mossoń, M. (2021) · Biomolecules · doi:10.3390/biom11081208 · Cited by 15 · see citing works

Targeting CAFs and extracellular matrix (ECM) in lung cancer: Potential of adjuvants and nanoparticles

Feng, Y., Jiang, Y., Yang, L., Lu, D., Li, N., Zhang, Q., Yang, H., Qin, H., Zhang, J., Gou, X., et al. (2025) · Bioorganic Chemistry · doi:10.1016/j.bioorg.2025.108586 · Cited by 14 · see citing works

Pirfenidone inhibits TGF‐β1‐induced metabolic reprogramming during epithelial‐mesenchymal transition in non‐small cell lung cancer

Zhang, S., Wang, Y., Luo, D., Cheng, Z., Zeng, Q., Wang, G., Chen, M., Zhang, S., & Luo, P. (2023) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.18059 · Cited by 13 · see citing works

CRKL promotes hepatocarcinoma through enhancing glucose metabolism of cancer cells via activating PI3K/Akt

Guo, C., Gao, C., Lv, X., Zhao, D., Greenaway, F. T., Hao, L., Tian, Y., Liu, S., & Sun, M. (2021) · Journal of Cellular and Molecular Medicine · doi:10.1111/jcmm.16303 · Cited by 13 · see citing works

Acute Influenza Infection Promotes Lung Tumor Growth by Reprogramming the Tumor Microenvironment

Garmendia, I., Varthaman, A., Marmier, S., Angrini, M., Matchoua, I., Darbois, A., Josseaume, N., Foy, P.-E., Roumenina, L. T., Naouar, N., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0534 · Cited by 13 · see citing works

The Dual Role of Metformin: Repurposing an Antidiabetic Drug for Cancer Therapy

Barbosa, F., Cunha, A., Barbosa, J., Faria, J., & Queirós, O. (2025) · Applied Sciences · doi:10.3390/app152111576 · Cited by 13 · see citing works

Metabolism-Related Gene Expression in Circulating Tumor Cells from Patients with Early Stage Non-Small Cell Lung Cancer

Zafeiriadou, A., Kollias, I., Londra, T., Tsaroucha, E., Georgoulias, V., Kotsakis, A. P., Lianidou, E. S., & Markou, A. N. (2022) · Cancers · doi:10.3390/cancers14133237 · Cited by 12 · see citing works

Genome-scale models as a vehicle for knowledge transfer from microbial to mammalian cell systems

Strain, B., Morrissey, J., Antonakoudis, A., & Kontoravdi, C. (2023) · Computational and Structural Biotechnology Journal · doi:10.1016/j.csbj.2023.02.011 · Cited by 11 · see citing works

Cytotoxic potential on human breast and lung cancer cells of the biosynthesized gold nanoparticles from the reduction of chloroauric acid by lactic acid isolated from Lactobacillus acidophilus

Repotente, E. C. T., Carreon, A. J., Devanadera, M. K., Esmalla, M. S., & Santiago-Bautista, M. R. (2022) · Frontiers in Materials · doi:10.3389/fmats.2022.933749 · Cited by 11 · see citing works

Immunonutrition, Metabolism, and Programmed Cell Death in Lung Cancer: Translating Bench to Bedside

Fedele, P., Santoro, A. N., Pini, F., Pellegrino, M., Polito, G., Luca, M. C. D., Pignatelli, A., Tancredi, M., Lagattolla, V., Anglani, A., et al. (2024) · Biology · doi:10.3390/biology13060409 · Cited by 11 · see citing works

PFKFB3-dependent redox homeostasis and DNA repair support cell survival under EGFR-TKIs in non-small cell lung carcinoma

Lypova, N., Dougherty, S. M., Clem, B. F., Feng, J. C., Yin, X., Zhang, X., Li, X., Chesney, J. A., & Imbert-Fernandez, Y. (2024) · Cancer & Metabolism · doi:10.1186/s40170-024-00366-y · Cited by 11 · see citing works

Multi-Omics Integration-Based Prioritisation of Competing Endogenous RNA Regulation Networks in Small Cell Lung Cancer: Molecular Characteristics and Drug Candidates

Wang, X., Gao, J., Yu, Q., Zhang, M., & Hu, W. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.904865 · Cited by 11 · see citing works

RIPOR2 Expression Decreased by HPV-16 E6 and E7 Oncoproteins: An Opportunity in the Search for Prognostic Biomarkers in Cervical Cancer

Olmedo‐Nieva, L., Muñoz-Bello, J. O., Martínez-Ramírez, I., Martínez-Gutiérrez, A. D., Ortiz-Pedraza, Y., González‐Espinosa, C., Madrid‐Marina, V., Torres-Poveda, K., Bahena-Román, M., & Lizano, M. (2022) · Cells · doi:10.3390/cells11233942 · Cited by 11 · see citing works

Anti-Glycolytic Drugs in the Treatment of Hepatocellular Carcinoma: Systemic and Locoregional Options

Masouleh, M. P., Haghani, L., Zhao, K., Karimi, A., Marinelli, B. S., Erinjeri, J. P., Geschwind, J. H., & Yarmohammadi, H. (2023) · Current Oncology · doi:10.3390/curroncol30070485 · Cited by 11 · see citing works

Mushroom-Derived Compounds as Metabolic Modulators in Cancer

Dowaraka-Persad, B., & Neergheen, V. S. (2023) · Molecules · doi:10.3390/molecules28031441 · Cited by 10 · see citing works

Molecular mechanism of genetic, epigenetic, and metabolic alteration in lung cancer

Fatima, S., Kumar, V., & Kumar, D. (2025) · Medical Oncology · doi:10.1007/s12032-025-02608-5 · Cited by 11 · see citing works

Expression of SARS-COV-2 cell receptor gene ACE2 is associated with immunosuppression and metabolic reprogramming in lung adenocarcinoma based on bioinformatics analyses of gene expression profiles

Uddin, M. N., Akter, R., Li, M., & Abdelrahman, Z. (2021) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2021.109370 · Cited by 10 · see citing works

Prediabetes and the risk of lung cancer incidence and mortality: A meta‐analysis

Shen, E., & Chen, X. (2023) · Journal of Diabetes Investigation · doi:10.1111/jdi.14057 · Cited by 10 · see citing works

Cellular dynamics as a marker of normal-to-cancer transition in human cells

Marques, M. P. M., de Carvalho, A. L. M. B., Martins, C. B., Silva, J. D. S. E., Sarter, M., Sakai, V. G., Stewart, J. R., & de Carvalho, L. A. E. B. (2023) · Scientific Reports · doi:10.1038/s41598-023-47649-w · Cited by 10 · see citing works

Molecular Mechanisms of Chemoresistance Induced by Cisplatin in NSCLC Cancer Therapy

Kryczka, J., Kryczka, J., Czarnecka, K. H., & Brzeziańska‐Lasota, E. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22168885 · Cited by 13 · see citing works

Tuberculosis and lung cancer: metabolic pathways play a key role

Ferdosnejad, K., Zamani, M. S., Soroush, E., Fateh, A., Siadat, S. D., & Tarashi, S. (2024) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2024.2308522 · Cited by 9 · see citing works

NMR-Metabolomics Reveals a Metabolic Shift after Surgical Resection of Non-Small Cell Lung Cancer

Derveaux, E., Geubbelmans, M., Criel, M., Demedts, I., Himpe, U., Tournoy, K. G., Vercauter, P., Johansson, E., Valkenborg, D., Vanhove, K., et al. (2023) · Cancers · doi:10.3390/cancers15072127 · Cited by 9 · see citing works

Anti-tumor effects of novel alkannin derivatives with potent selectivity on comprehensive analysis

Dai, Z., Gao, F., Zhang, Z., Lu, M., Luo, Y.-J., Zhang, T., Shang, B., Gu, Y., Zeng, Q., Gao, S., et al. (2023) · Phytomedicine · doi:10.1016/j.phymed.2023.154912 · Cited by 9 · see citing works

Global, regional, and national burden of tracheal, bronchus, and lung cancers attributable to high fasting plasma glucose: A systematic analysis of global burden of disease 2019

Wang, M., Liu, J., Wang, J., Jin, Y., & Zheng, Z. (2023) · Journal of Diabetes · doi:10.1111/1753-0407.13499 · Cited by 9 · see citing works

Unraveling the Rewired Metabolism in Lung Cancer Using Quantitative NMR Metabolomics

Vanhove, K., Derveaux, E., Mesotten, L., Thomeer, M., Criel, M., Mariën, H., & Adriaensens, P. (2022) · International Journal of Molecular Sciences · doi:10.3390/ijms23105602 · Cited by 9 · see citing works

Metabolic dysregulations underlying the pulmonary toxicity of atmospheric fine particulate matter: focus on energy-producing pathways and lipid metabolism

Silva, T. D., Alves, C., Oliveira, H., & Duarte, I. (2022) · Air quality, atmosphere and health · doi:10.1007/s11869-022-01236-6 · Cited by 8 · see citing works

Imaging the Rewired Metabolism in Lung Cancer in Relation to Immune Therapy

van Genugten, E. A. J., Weijers, J. A., Heskamp, S., Kneilling, M., van den Heuvel, M., Piet, B., Bussink, J., Hendriks, L., & Aarntzen, E. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2021.786089 · Cited by 8 · see citing works

Memantine shifts cancer cell metabolism via AMPK1/2 mediated energetic switch in A549 lung cancer cells

Albayrak, G., & Korkmaz, F. D. (2020) · EXCLI journal · doi:10.17179/excli2020-2890 · Cited by 8 · see citing works

Metabolic signatures associated with oncolytic myxoma viral infections

Mahar, R., Ragavan, M., Chang, M. C., Hardiman, S., Moussatché, N., Behar, A., Renne, R., & Merritt, M. E. (2022) · Scientific Reports · doi:10.1038/s41598-022-15562-3 · Cited by 8 · see citing works

Lung metabolome of 1,3-butadiene exposed Collaborative Cross mice reflects metabolic phenotype of human lung cancer

Nellis, M. M., Caperton, C. O., Liu, K., Tran, V. T., Go, Y., Hallberg, L. M., Ameredes, B. T., Jones, D. P., & Boysen, G. (2021) · Toxicology · doi:10.1016/j.tox.2021.152987 · Cited by 8 · see citing works

GPX2 and BMP4 as Significant Molecular Alterations in The Lung Adenocarcinoma Progression: Integrated Bioinformatics Analysis.

Nazari, M. H. D., Dastjerdi, R. A., Talkhounche, P. G., Bereimipour, A., Mollasalehi, H., Mahshad, A. A., Razi, A., Nazari, M. H. D., Sadrabadi, A. E., & Taleahmad, S. (2022) · PubMed Central · doi:10.22074/cellj.2022.7930 · Cited by 7 · see citing works

Metabolic targeting, immunotherapy and radiation in locally advanced non-small cell lung cancer: Where do we go from here?

Dhawan, A., Pifer, P. M., Sandulache, V. C., & Skinner, H. D. (2022) · Frontiers in Oncology · doi:10.3389/fonc.2022.1016217 · Cited by 7 · see citing works

Systemic Analyses of the Expression of TPI1 and Its Associations with Tumor Microenvironment in Lung Adenocarcinoma and Squamous Cell Carcinoma

Yang, X., Ye, C., Zheng, H. W., Dai, C., & Zhu, Y. (2022) · Disease Markers · doi:10.1155/2022/6258268 · Cited by 6 · see citing works

FAK and p130Cas Modulate Stiffness‐Mediated Early Transcription and Cellular Metabolism

Tumenbayar, B., Pham, K., Biber, J. C., Tutino, V. M., Brazzo, J. A., Yao, P., & Bae, Y. (2024) · Cytoskeleton · doi:10.1002/cm.21971 · Cited by 5 · see citing works

A method for the identification of lactate metabolism-related prognostic biomarkers and its validations in non-small cell lung cancer

Yang, W., Gu, M., Zhang, Y., Zhang, Y., Liu, T., Wu, D., Deng, J., Liu, M., & Zhang, Y. (2025) · Scientific Reports · doi:10.1038/s41598-025-85620-z · Cited by 5 · see citing works

Plasma Metabolite Profiling in the Search for Early-Stage Biomarkers for Lung Cancer: Some Important Breakthroughs

Meynen, J., Adriaensens, P., Criel, M., Louis, E., Vanhove, K., Thomeer, M., Mesotten, L., & Derveaux, E. (2024) · International Journal of Molecular Sciences · doi:10.3390/ijms25094690 · Cited by 5 · see citing works

Genome-wide screening and validation of exosome-derived TLN1 as a regulator of epithelial–mesenchymal transition in lung cancer

Ruan, X., Wan, X., Ma, W., Liu, J., Tian, T., Zhang, J., Zhi, J., Qiu, M., Zhao, M., Wang, Q., et al. (2025) · Scientific Reports · doi:10.1038/s41598-025-96210-4 · Cited by 4 · see citing works

GNE-493 suppresses gastric cancer development by targeting NAT10-mediated ac4C modification of HK2

Wang, T., Zhen, J., Wei, Q., Ji, R., Liu, G., Lin, S., Lu, J., & Wang, Q. (2026) · Cellular Signalling · doi:10.1016/j.cellsig.2026.112441 · Cited by 4 · see citing works

The Altered Metabolic Molecular Signatures Contribute to the RAD001 Resistance in Gastric Neuroendocrine Tumor

Pan, J., Bao, Q., & Enders, G. A. (2020) · Frontiers in Oncology · doi:10.3389/fonc.2020.00546 · Cited by 4 · see citing works

Ginsenoside Rk1 inhibits the malignant progression of lung cancer by inactivating the INSR/PI3K/AKT pathway

Du, N., Song, D., Sun, X., Ren, H., & Zhang, Y. (2025) · Tissue and Cell · doi:10.1016/j.tice.2025.102880 · Cited by 3 · see citing works

Lung Cancer: Pathophysiology and Current Advancements in Therapeutics

Thirusangu, P., & Vigneshwaran, V. (2020) · Springer eBooks · doi:10.1007/978-981-15-3734-9_6 · Cited by 3 · see citing works

Derivation of a Novel CIHI in Patients with Lung Adenocarcinoma for Estimating Tumor Microenvironment and Clinical Prognosis

Zhou, L., Xu, G., Wang, L., Zhang, J., & Li, W. (2021) · Disease Markers · doi:10.1155/2021/4495489 · Cited by 3 · see citing works

A benzimidazole derivative as an effective antitumor agent in terms of syngeneic lung tumors and melanoma treatment

Komarova, E. F., Морковник, А. С., Zhukovskaya, O. N., Verenikina, E. V., Shevchenko, N. A., Владиславовна, Х. Д., Kurbanova, L. Z., Вадимовна, М. М., Заикина, Е. В., & Galina, A. V. (2022) · South Russian Journal of Cancer · doi:10.37748/2686-9039-2022-3-1-2 · Cited by 3 · see citing works

Drivers of Glucose and Glutamine Metabolism Reprogramming in Tumor Cells and Their Potential as Target for Cancer

Mekuria, A. N., & Abdi, A. D. (2018) · Journal of Tumor Research · doi:10.35248/2684-1258.18.4.139 · Cited by 2 · see citing works

Alternative Energy: Breaking Down the Diverse Metabolic Features of Lung Cancers

Cargill, K. R., Hasken, W. L., Gay, C. M., & Byers, L. A. (2021) · Frontiers in Oncology · doi:10.3389/fonc.2021.757323 · Cited by 21 · see citing works

Tumor metabolic reprogramming in lung cancer progression (Review)

Li, X., Liu, M., Liu, H., & Chen, J. (2022) · Oncology Letters · doi:10.3892/ol.2022.13407 · Cited by 52 · see citing works

GLUCOSE METABOLIC REPROGRAMMING IN CANCER CELLS: MOLECULAR BASIS, REGULATORY NETWORKS, AND THERAPEUTIC OPPORTUNITIES

Saydullayeva, G., Jo'rayev, A., Ro'zimatov, B., & Saydullayeva, G. (2026) · Central Asian Journal of Academic Research · doi:10.70413/cajar-v04-i03-s48395

Biology of glucose metabolization in cancer cells

Fadaka, A. O., Ajiboye, B. O., Ojo, O. A., Adewale, O. B., Olayide, I., & Emuowhochere, R. (2017) · Journal of Oncological Sciences · doi:10.1016/j.jons.2017.06.002 · Cited by 301 · see citing works